Overview
Updated 14 Jul 2026
Mary Beth Scholand, MD, is Associate Professor of Medicine, Division of Respiratory, Critical Care, and Occupational Pulmonary Medicine at University of Utah Health / Spencer Fox Eccles School of Medicine, Salt Lake City, UT. The public record shows 163 publications with 7,720 citations (h-index 44), centered on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis, Systemic Sclerosis and Related Diseases, Chronic Obstructive Pulmonary Disease (COPD) Research. It also documents an investigator role on 8 registered clinical trials, industry payments reported by 11 companies.
- Most recent indexed publication: 2024 · Annals of internal medicine
- Top research focus: Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- 8 registered trials on ClinicalTrials.gov
- Open Payments reporting from 11 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 4 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 76.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 8 registered studies on ClinicalTrials.gov. The most recent:
- Autoantibody Reduction Therapy for Progressive Idiopathic Pulmonary Fibrosis
Sponsor: University of Alabama at Birmingham
InvestigatorPhase 2Not, yet, recruitingNCT07674745 - A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Sponsor: Rein Therapeutics
InvestigatorPhase 2RecruitingNCT06968845 - An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Sponsor: Avalyn Pharma Inc.
InvestigatorPhase 2RecruitingNCT06951217
Industry payments
Updated 14 Jul 2026
11 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Daiichi Sankyo Inc.Program year202534 payments$35,891openpaymentsdata.cms.gov ↗
- United Therapeutics CorporationProgram year202531 payments$30,833openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202518 payments$19,843openpaymentsdata.cms.gov ↗
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline.
American journal of respiratory and critical care medicine
2024 - Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis.
The European respiratory journal
2021 - Physiological predictors of survival in patients with sarcoidosis-associated pulmonary hypertension: results from an international registry.
The European respiratory journal
2020
Most-cited worksby citation count (OpenAlex)
Contact
No public contact details on file. This person's NPPES record doesn't include a practice address or telephone number. Why? →
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
- Internal Medicine Residency
Washington University/Barnes-Jewish Hospital/St. Louis Children's Hospital Consortium
1993provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
- Board Certified
Internal Medicine (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗ - Board Certified
Pulmonary Disease (American Board of Internal Medicine)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthgrades.com ↗
Editorial & leadership rolesjournal and society appointments
- Director
Interstitial Lung Disease Clinic, University of Utah Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healthcare.utah.edu ↗ - Clinical Research Compliance Director
Department of Internal Medicine, University of Utah
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →medicine.utah.edu ↗ - Faculty Mentor
Office of Undergraduate Research, University of Utah
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →our.utah.edu ↗
Awards & honorshonors on the public record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →google.com ↗
Secondary affiliationsappointments beyond the home institution
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Media & interviewspress, podcasts and appearances
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →rarediseaseadvisor.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/mary-beth-scholand-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Other
rarediseaseadvisor.com/podcasts/dr-mary-beth-scholand-chest-three-lakes-foundation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →rarediseaseadvisor.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Jamie Dwyer, MD
University of Utah
- 162
- publications
- 43
- h-index
- 2
- trials
Brian Mickey, MD
University of Utah
- 131
- publications
- 32
- h-index
- 4
- trials